Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
Ocumension Therapeutics ᆄੰၪൖ͛ي
(Incorporated in the Cayman Islands with limited liability)
(Stock code: 1477)
VOLUNTARY ANNOUNCEMENT
INCLUSION OF THE SHARES OF THE COMPANY IN THE HONG KONG STOCK CONNECT LIST UNDER THE SHENZHEN-HONG KONG STOCK
CONNECT
This announcement is made by Ocumension Therapeutics (the "Company", together with its subsidiaries, the "Group") on a voluntary basis.
The board of directors of the Company (the "Board") is pleased to announce that the Company has been included in the Hong Kong Stock Connect list under the Shenzhen-Hong Kong Stock Connect, with effect on March 15, 2021, pursuant to the Announcement on Adjustment of the stock list of Connect Stock Hong Kong under Shenzhen-Hong Kong Stock Connect issued by the Shenzhen Stock Exchange on March 15, 2021.
The Board is of the view that the inclusion of the Company in the Hong Kong Stock Connect list under the Shenzhen-Hong Kong Stock Connect demonstrates the recognition of the Company's business, liquidity of stock and future prospect of the Company by the investors in the capital markets, and such inclusion is expected to expand the shareholder base, diversify the shareholder structure and increase the trading liquidity of the Company. It is expected that the inclusion will further facilitate realizing the investment value of the Company and enhancing the Company's reputation in the capital market.
The Board would like to thank the shareholders of the Company and investors for their continued support of the Company. The Company endeavors to make use of its competitive advantages to expand its business and to create value for its stakeholders.
By order of the Board
Ocumension Therapeutics
Dr. Lian Yong CHEN
Chairman and Executive Director
Hong Kong, March 15, 2021
As of the date of this announcement, the Board comprises Dr. Lian Yong CHEN, Mr. Ye LIU, Dr. Zhaopeng HU and Dr. Wei LI as executive directors, Mr. Yanling CAO and Mr. Lefei SUN as non-executive directors, and Mr. Ting Yuk Anthony WU, Mr. Lianming HE, and Mr. Yiran HUANG as independent non-executive directors.